GLP-2 TZ

GLP-2 TZ — Dual Receptor Agonist Research Peptide
GLP-2 TZ is a next-generation research peptide engineered to simultaneously target GLP-1 and GIP receptors. This dual agonist mechanism has become a major focus of metabolic research due to its effects on glucose regulation and energy balance.
Mechanism Of Action
GLP-2 TZ activates glucagon-like peptide-1 (GLP-1) receptors to enhance glucose-dependent insulin signaling while also stimulating glucose-dependent insulinotropic polypeptide (GIP) receptors to support incretin activity. The combined action creates a synergistic metabolic response studied extensively in preclinical models.
Research Applications
Metabolic pathway modulation
Glucose regulation studies
Insulin sensitivity investigations
Appetite signaling research
Comparative dual agonist analysis
Product Specifications
Quantity: Varied per vial
Purity: ≥99% (HPLC verified)
Form: Lyophilized powder
Storage: Refrigerate after reconstitution
Testing: USA lab tested, COA available
For research purposes only. Not for human use or consumption.